The global balloon catheters market, by Product Type (Over-the-wire (OTW) Balloon Catheters, Rapid Exchange (RX) Balloon Catheters, and Fixed-wire (FW) Balloon Catheters),by Balloon Type (Noncompliant (High-pressure) Balloons, Semi-compliant (Midpressure) Balloons, and Compliant (Elastomeric) Balloons), by Material (Polyurethane, Nylon, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 11,463.0 million in 2018, and is expected to exhibit a CAGR of 5.3% over the forecast period (2019 - 2027). Manufacturer are focusing on expansion of their manufacturing facilities, in order to strengthen their market presence and enhance their product portfolio. With this, manufactures are expected to penetrate into large untapped markets in the emerging economies, which is expected to increase the number of balloon catheter manufacturing globally. For instance, in April 2019, Biomerics LLC completed an expansion of its advanced catheter facility located in Brooklyn Park, U.S. With this, company added 10,000 square feet of engineering, office, and production space to the existing facility for the production of advanced catheter. The advanced catheter segment of the Biometric offers various products such as balloons and balloons catheters, micro-catheters, reinforced sheaths, steerable, procedural devices, and others components. This facility expansion for the production of large volume of the balloons catheters is expected to drive the balloon catheters market growth over the forecast period. Browse 32 Market Data Tables and 26 Figures spread through 168 Pages and in-depth TOC on ‘Balloon Catheters Market, by Product Type (Over-the-wire (OTW) Balloon Catheters, Rapid Exchange (RX) Balloon Catheters, and Fixed-wire (FW) Balloon Catheters),by Balloon Type (Noncompliant (High-pressure) Balloons, Semi-compliant (Midpressure) Balloons, and Compliant (Elastomeric) Balloons), by Material (Polyurethane, Nylon, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), Global Forecast to 2027’ To know the latest trends and insights related to global balloon catheters market, click the link below: https://www.coherentmarketinsights.com/market-insight/balloon-catheters-market-489 Increasing regulatory approval for different types of balloon catheter is expected to drive balloon catheters market growth over the forecast period. For instance, in August 2016, BrosMed Medical Co., Ltd., a medical device company headquartered in Dongguan, China, received the U.S. FDA approval for its Apollo NC PTCA Balloon Catheters for sale in the U.S. and the North America market for the interventional cardiovascular use. The novel balloon catheter is intended for percutaneous transluminal coronary angioplasty. Moreover the company also received the CE marking for its Minerva percutaneous transluminal angioplasty (PTA) dilatation balloon catheter in April 2015. The Minerva PTA dilation balloon catheter was designed for the treatment of patients with peripheral arterial disease. Rising adoption of inorganic strategies such as acquisitions by major players is expected to drive the balloon catheters market growth over the forecast period. For instance, in October 2018, Nordson Corporation acquired Clada Medical Devices, an Ireland-based design and development company focused on balloon catheters. The acquisition enhanced the Nordson Medical’s design and development capabilities and also strengthened its position in the full-device solution and component manufacturing for original equipment manufacturer (OEM’s) across interventional and surgical medical devices. Furthermore, the emergence of the highly innovative and effective balloon catheters such as drug eluting balloon catheters have gained significant traction in the treatment of for treating coronary artery disease (CAD). Drug eluting balloon catheters are the conventional semi-compliant angioplasty balloons catheters with an anti-proliferative drug which is released into the vessel wall during inflation of the balloon. Many manufactures are focusing on development such drug eluting balloon catheters, which is expected to drive the global balloon catheters market growth. For instance, in March 2019, MedAlliance SA, a Switzerland-based company received Breakthrough Device Designation (BDD) from the U.S. Food and Drug Administration (FDA) for its product ‘Selution’. Selutions is a sustained limus release (SLR) drug-eluting balloon (DEB) catheter, for the treatment of coronary disease. Key Takeaways of the Global Balloon Catheters Market:
- The global balloon catheters market is expected to exhibit a CAGR of 5.3% during the forecast period (2019 – 2027), owing to increasing number of product launches for balloon catheters
- Increasing acquisition by key players focused on developing personalized cell therapies is expected to drive the balloon catheters market growth. For instance, in October 2017, Boston Scientific acquired Apama Medical Inc, a company that specializes in innovative Apama Radiofrequency (RF) balloon catheter system. This acquisition has allowed Boston Scientific to enhance its continued investment in the electrophysiology category, and to strengthened portfolio of differentiated arrhythmia solution
- Major players operating in the global balloon catheters market include Abbott Laboratories, Becton Dickinson and Company, Boston Scientific Corporation, Bard Medical Division, B. Braun Melsungen AG, Johnson & Johnson, Teleflex Incorporated, Medtronic, Plc. Edwards Lifesciences Corporation, and Vascular Solutions, Inc.
